Advertisement

Abdominal Imaging

, Volume 34, Issue 5, pp 588–592 | Cite as

Ablation of adrenal neoplasms

  • Michael D. Beland
  • William W. Mayo-Smith
Article

Abstract

Adrenal tumors represent a diverse group of neoplasms that include multiple etiologies, each with a different prognosis, malignant potential, and recommended treatment. Percutaneous techniques to treat adrenal neoplasms have been described including radiofrequency ablation, cryoablation, and chemical ablation. This article reviews the various adrenal neoplasms and the techniques of adrenal ablation.

Keywords

Radiofrequency ablation Ablation Cryoablation Chemical ablation Adrenal neoplasm 

References

  1. 1.
    Commons RR, Calloway CP 1948. Adenomas of the adrenal cortex. Arch Inter Med. 81:37Google Scholar
  2. 2.
    Pacek K, Fojo T, Goldstein DS, et al. 2001. Radiofrequency Ablation (RFA): a novel approach for the treatment of metastatic pheochromocytoma. J Natl Cancer Inst 93:648–649CrossRefGoogle Scholar
  3. 3.
    Mayo-Smith WW, Dupuy DE, 2004. CT guided radiofrequency ablation of adrenal neoplasms: preliminary results. Radiology. 231:225–230PubMedCrossRefGoogle Scholar
  4. 4.
    Wood BJ, Abraham J, Hvizda JL, et al. 2003. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 97(3):554–560PubMedCrossRefGoogle Scholar
  5. 5.
    Inoue H, Nakajo M, Miyazono N, et al. 1997. Transcatheter arterial ablation of aldosteronomas with high-concentration ethanol: preliminary and long-term results. AJR Am J Roentgenol 168:1241–1245PubMedGoogle Scholar
  6. 6.
    Miyazono N, Ueno K, Nakajo M, et al. 1996. Transcatheter arterial and adrenal embolization with iohexol–ethanol solutions: animal experimental study and clinical application. Invest Radiol. 31:755–760PubMedCrossRefGoogle Scholar
  7. 7.
    Shibata T, Maetani Y, Ametani F, et al. 2000. Percutaneous ethanol injection for treatment of adrenal metastasis from hepatocellular carcinoma. Am J Roentgenol. 174:333–335. Google Scholar
  8. 8.
    Maki DD, Haskal ZJ, Matthies A, et al. 2000. Percutaneous ethanol ablation of an adrenal tumor. Am J Roentgenol. 174:1031–1032Google Scholar
  9. 9.
    Liang HL, Pan HB, Lee YH, et al. 1999. Small functional adrenal cortical adenoma: treatment with CT-guided percutaneous acetic acid injection-report of three cases. Radiology. 213:612–615PubMedGoogle Scholar
  10. 10.
    Mayo-Smith WW, Boland GW, Noto RB, Lee MJ 2001. State of the art adrenal imaging. Radiographics 21:995–1012PubMedGoogle Scholar
  11. 11.
    Song JH, Chaudhry FS, Mayo-Smith WW 2008. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. Am J Roentgenol. 190(5):1163–1168CrossRefGoogle Scholar
  12. 12.
    Demeure MJ, Somberg LB 1998. Functioning and nonfunctioning adrenocortical carcinoma: clinical presentation and therapeutic strategies. Surg Oncol Clin North Am. 7:791–805Google Scholar
  13. 13.
    Brennan MF 1987. Adrenocortical carcinoma. CA Cancer J Clin. 37:349–365CrossRefGoogle Scholar
  14. 14.
    Pommier RF, Brennan MF 1992. An eleven-year experience with adrenocortical carcinoma. Surgery. 112:963–971PubMedGoogle Scholar
  15. 15.
    Williams G (1998) Harrison’s principles of internal medicine (14th ed.) (Fauci AS, Braunwald KJ, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, Horrison TR, Eds.). New York, NY: McGraw-HillGoogle Scholar
  16. 16.
    Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol. 21:315–318PubMedCrossRefGoogle Scholar
  17. 17.
    Dunnick N 1990. Adrenal imaging: current status. Am J Roentgenol. 15:927–936Google Scholar
  18. 18.
    Dunnick NR, Leight GS Jr, Roubidoux MA, et al. 1993. CT in the diagnosis of primary aldosteronism: sensitivity in 29 patients. Am J Roentgenol 160(2):321–324Google Scholar
  19. 19.
    Paul CA, Virgo KS, Wade TP, Audisio RA, Johnson FE 2000. Adrenalectomy for isolated adrenal metastases from non-adrenal cancer. Int J Oncol 17:181–187PubMedGoogle Scholar
  20. 20.
    Lo CY, Van Heerden JA, Soreide JA, et al. 1996. Adrenalectomy for metastatic disease to the adrenal glands. Br J Surg. 83:528–531PubMedCrossRefGoogle Scholar
  21. 21.
    Kim SH, Brennan MF, Russo P, Burt ME, Coit DG (1998) The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 82:389–394Google Scholar
  22. 22.
    Goldberg SN, Dupuy DE 2001. Image-guided radiofrequency tumor ablation: challenges and opportunities. I. J Vasc Interv Radiol. 12:1021–1032CrossRefGoogle Scholar
  23. 23.
    Chen EA, Neeman Z, Lee FT, Kam A, Wood B 2006. Thermal protection with 5% dextrose solution blanket during radiofrequency ablation. Cardiovasc Intervent Radiol. 29(6):1093–1096PubMedCrossRefGoogle Scholar
  24. 24.
    Kariya S, Tanigawa N, Kojima H, et al. 2005. Radiofrequency ablation combined with CO2 injection for treatment of retroperitoneal tumor: protecting surrounding organs against thermal injury. Am J Roentgenol. 185:890–893CrossRefGoogle Scholar
  25. 25.
    Dodd GD III, Soulen MC, Kane RA, et al. (2000) Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 20:9–27Google Scholar
  26. 26.
    Schulsinger DA, Sosa RE, Perlmutter AA, Vaughan ED Jr 1999. Acute and chronic interstitial cryotherapy of the adrenal gland as a treatment modality. J Endourol. 13:299–303PubMedCrossRefGoogle Scholar
  27. 27.
    R Munver, JJ Del Pizzo, RE Sosa 2003. Adrenal-preserving minimally invasive surgery: the role of laparoscopic partial adrenalectomy, cryosurgery, and radiofrequency ablation of the adrenal gland. Curr Urol Rep. 4:87–92PubMedCrossRefGoogle Scholar
  28. 28.
    Atwell T, Wass C, Charboneau J, et al. 2006. Malignant hypertension during cryoablation of an adrenal gland tumor. J Vasc Interv Radiol. 17(3):573–575PubMedCrossRefGoogle Scholar
  29. 29.
    Liang HL, Liang HL, Mar GY, Chiang HT, Liu CP 2000. Computerized-tomography-guided percutaneous tumor ablation using acetic acid injection in an aldosterone-producing tumor: a novel therapy. ZhonghuaYi Xue Za Zhi (Taipei). 63:833–837Google Scholar
  30. 30.
    Xiao YY, Tian JL, Li JK, Yang L, Zhang JS 2008. CT-guided percutaneous chemical ablation of adrenal neoplasms. Am J Roentgenol. 190:105–110CrossRefGoogle Scholar
  31. 31.
    Onik G, Onik C, Medary I, et al. (2003) Life threatening hypertensive crises in two patients undergoing hepatic radiofrequency ablation. Am J Roentgenol 181:495–497Google Scholar
  32. 32.
    Sudheendra Wood DBJ, 2006. Appropriate premedication risk reduction during adrenal ablation. J Vasc Interv Radiol. 17(8):1367–1368Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Department of Diagnostic ImagingRhode Island Hospital, The Warren Alpert Medical School of Brown UniversityProvidenceUSA

Personalised recommendations